Scientists at Xi'an Jiaotong-Liverpool University (XJTLU) and Nanjing University in China have developed a new drug delivery ...

Drug Delivery Systems (DDS) are the advanced formulations or technologies that modulate the release profile of therapeutic or prophylactic agents, their absorption, distribution and elimination ...

Georgia Institute of Technology. "Oral delivery system to treat inflammatory bowel diseases developed." ScienceDaily. www.sciencedaily.com / releases / 2010 / 10 / 101010133633.htm (accessed June ...

When tested in a mouse model of breast cancer, the doxorubicin-loaded nanoparticles caused fewer side effects than free ...

Developing new drugs to treat long-existing diseases is vital, but many of these medications don’t reach their targets ...

An estimated 322,600 Canadians have inflammatory bowel disease (IBD) as of 2023, and Canada has one of the highest incidence rates in the world, according to Crohn’s and Colitis Canada.

Sometimes, innovation in delivery systems for well-know and established therapeutics may be just as disruptive as the new targeted medicine. Newsletters Games Share a News Tip Featured ...

Gene Therapy: Oral Gene Delivery System For Inflammatory Bowel Disease Works, Study Shows. ScienceDaily . Retrieved June 4, 2025 from www.sciencedaily.com / releases / 2008 / 05 / 080520163044.htm ...

Drug penetrability and; Safety of the implantation procedure. Further improvement of polymeric drug delivery systems will require that a larger volume of brain parenchyma is selectively targeted.

Scientists at Xi'an Jiaotong-Liverpool University (XJTLU) and Nanjing University in China have developed a new drug delivery ...

By 2019, there were 46,074 patients with IBD in Israel, corresponding to a national prevalence of 519 per 100,000, of whom 54.1% had Crohn’s and 45.9% had ulcerative colitis.